A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 6,300 shares of PBH stock, worth $534,555. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,300
Previous 1,400 350.0%
Holding current value
$534,555
Previous $96,000 372.92%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$65.26 - $75.5 $5.13 Million - $5.94 Million
-78,657 Reduced 77.78%
22,465 $1.62 Million
Q2 2024

Aug 14, 2024

SELL
$62.62 - $71.76 $5.63 Million - $6.45 Million
-89,905 Reduced 47.06%
101,122 $6.96 Million
Q1 2024

May 15, 2024

BUY
$58.76 - $75.07 $9.99 Million - $12.8 Million
170,031 Added 809.83%
191,027 $13.9 Million
Q4 2023

Feb 14, 2024

SELL
$57.0 - $61.94 $5.9 Million - $6.41 Million
-103,545 Reduced 83.14%
20,996 $1.29 Million
Q3 2023

Nov 14, 2023

BUY
$56.7 - $68.29 $3.87 Million - $4.67 Million
68,328 Added 121.55%
124,541 $7.12 Million
Q2 2023

Aug 14, 2023

SELL
$56.28 - $63.76 $319,726 - $362,220
-5,681 Reduced 9.18%
56,213 $3.34 Million
Q1 2023

May 15, 2023

SELL
$58.41 - $67.05 $568,738 - $652,865
-9,737 Reduced 13.59%
61,894 $3.88 Million
Q4 2022

Feb 14, 2023

BUY
$49.75 - $63.89 $1.68 Million - $2.16 Million
33,835 Added 89.52%
71,631 $4.48 Million
Q3 2022

Nov 14, 2022

SELL
$48.72 - $61.12 $755,793 - $948,154
-15,513 Reduced 29.1%
37,796 $1.88 Million
Q2 2022

Aug 15, 2022

SELL
$52.06 - $58.9 $5.83 Million - $6.6 Million
-112,042 Reduced 67.76%
53,309 $3.14 Million
Q1 2022

May 16, 2022

BUY
$52.94 - $61.88 $5.13 Million - $6 Million
96,891 Added 141.53%
165,351 $8.75 Million
Q4 2021

Feb 14, 2022

BUY
$55.41 - $63.3 $2.38 Million - $2.71 Million
42,875 Added 167.58%
68,460 $4.15 Million
Q3 2021

Nov 15, 2021

SELL
$51.0 - $60.54 $915,807 - $1.09 Million
-17,957 Reduced 41.24%
25,585 $1.44 Million
Q2 2021

Aug 16, 2021

SELL
$42.92 - $53.03 $109,617 - $135,438
-2,554 Reduced 5.54%
43,542 $2.27 Million
Q1 2021

May 17, 2021

SELL
$36.16 - $47.63 $739,869 - $974,557
-20,461 Reduced 30.74%
46,096 $2.03 Million
Q4 2020

Feb 16, 2021

BUY
$32.69 - $37.69 $980,601 - $1.13 Million
29,997 Added 82.05%
66,557 $2.32 Million
Q3 2020

Nov 16, 2020

SELL
$34.54 - $40.79 $1.45 Million - $1.71 Million
-41,937 Reduced 53.42%
36,560 $1.33 Million
Q2 2020

Aug 14, 2020

BUY
$36.63 - $44.07 $694,504 - $835,567
18,960 Added 31.85%
78,497 $2.95 Million
Q1 2020

May 15, 2020

SELL
$29.5 - $45.96 $351,728 - $547,981
-11,923 Reduced 16.68%
59,537 $2.18 Million
Q4 2019

Feb 14, 2020

BUY
$33.75 - $41.12 $893,902 - $1.09 Million
26,486 Added 58.89%
71,460 $2.89 Million
Q3 2019

Nov 14, 2019

BUY
$29.93 - $36.8 $916,606 - $1.13 Million
30,625 Added 213.43%
44,974 $1.56 Million
Q2 2019

Aug 14, 2019

SELL
$27.65 - $31.68 $4.15 Million - $4.76 Million
-150,096 Reduced 91.27%
14,349 $455,000
Q1 2019

May 15, 2019

SELL
$26.79 - $31.72 $3.17 Million - $3.75 Million
-118,163 Reduced 41.81%
164,445 $0
Q4 2018

Feb 14, 2019

SELL
$29.28 - $41.29 $2.22 Million - $3.13 Million
-75,787 Reduced 21.15%
282,608 $8.73 Million
Q3 2018

Nov 13, 2018

BUY
$34.44 - $39.35 $1 Million - $1.15 Million
29,131 Added 8.85%
358,395 $0
Q2 2018

Aug 10, 2018

BUY
$28.49 - $38.41 $3.12 Million - $4.2 Million
109,402 Added 49.76%
329,264 $0
Q1 2018

May 11, 2018

BUY
$32.94 - $46.03 $4.1 Million - $5.73 Million
124,560 Added 130.7%
219,862 $7.41 Million
Q4 2017

Feb 09, 2018

BUY
$40.63 - $50.91 $3.62 Million - $4.54 Million
89,133 Added 1444.85%
95,302 $4.23 Million
Q3 2017

Nov 09, 2017

BUY
$48.69 - $53.63 $300,368 - $330,843
6,169
6,169 $309,000

Others Institutions Holding PBH

About Prestige Consumer Healthcare Inc.


  • Ticker PBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,762,600
  • Market Cap $4.22B
  • Description
  • Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...
More about PBH
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.